====== Boehringer Ingelheim ======

{{ :pharmaceutical_companies:boehringer.png?200|}}

===== COVID-19 =====

Boehringer Ingelheim is a member of the [[:Corona Accelerated R&D in Europe]] (CARE), developing therapeutics for COVID-19.((//COVID-19: CARE Consortium.// Boehringer Ingelheim. Retrieved January 12, 2022, from https://archive.ph/wiSRG))

The company ran clinical trials for their neutralizing antibody product BI 764198 in [[:COVID-19]] patients. The trials were suspended due to lack of efficacy.((//Study in COVID-19 Patients with Severe Respiratory Illness Discontinued.// Boehringer Ingelheim. Retrieved January 12, 2022, from
https://www.boehringer-ingelheim.com/covid-19/fighting-covid-19/research-update))

They also manufacture veterinary [[:ivermectin]] products and advises against human consumption, instead advocating for COVID-19 vaccination.((//Ivermectin in Animal Health products and COVID-19.// Boehringer Ingelheim. Retrieved January 12, 2022, from
https://archive.ph/sSaLf))